We are very excited to announce the appointment of Pierre-HenriBaviera as the new CEO for Mias Pharma Limited.
As an experienced CEO, Pierre brings significant senior international leadership capabilities in Professional Services and Technology companies. He will be focused on the next phase of growth for MIAS’s people and customers in line with our mission to accelerate the availability of medicines to patients within the EU.
Pierre is taking over from MIAS Founder Ann McGee who led the company from inception to exponential growth and who will be moving into a new role as Chief Innovation Officer and interim Quality Director.
